Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios

Jenny HarlettPress Release

Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of a new feature to its Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Bluesight for Controlled Substances’ Investigation Portfolios tool was designed … Read More

Kit Check and Sandoz agree to a commercialization collaboration that helps improve hospital medication administration safety

Jenny HarlettPress Release

Implementation of Kit Check RFID technology enables accuracy and visibility of hospital medications, from the production line to the patient Washington DC, June 27, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, along with Sandoz, a Novartis division, today announced a commercialization and supply agreement that will allow Sandoz generic injectable products to operate out … Read More

Kit Check Brings Next-Generation Medication Tracking Mainstream with FDA Pilot

Jenny HarlettPress Release

Pilot looks to implement tech that improves the tracking of powerful drugs and interoperability of software throughout the supply chain Group initiative brings together industry leaders such as Nephron Pharmaceuticals, Sandoz, Coral Gables Hospital and Hackensack University Medical Center Washington DC, June 11, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, today announced the acceptance … Read More

Hospital Pharmacy Operations Report Shows Half of All Hospitals Have Experienced Drug Diversion in the Last Six Months and Points to Lack of Visibility, Tools and Resources

Ava MutchlerPress Release

Kit Check, the leader in automated medication management solutions for hospitals, today announced the findings of its 2018 Hospital Pharmacy Operations Report, which surveyed pharmacy leaders affiliated with over 1,000 hospitals across the United States. The findings are published on the heels of a recent analysis of 1 million controlled substance cases which was executed utilizing Kit Check’s artificial intelligence solution for drug diversion, Bluesight for Controlled Substances.

Kit Check Announces Strategic Additions to Leadership Team

Ava MutchlerPress Release

Kit Check, the leader in automated medication management solutions for hospitals, today announced new appointments to its leadership team to help foster the company’s continuous growth and increase its recognition amongst hospitals across the country. The appointments cement the company’s focus on improving medication management processes within the hospital as well as amplify their continued efforts to decrease drug diversion.

Kit Check Announces “Works with Kit Check” Certification Program for Hospital Pharmacy Vendors

Ava MutchlerPress Release

The program, which includes nine launch partners, provides assurance of Kit Check compatibility with hospital solutions ANAHEIM, CA (December 3, 2018) – Kit CheckTM, the leader in automated medication management solutions for hospitals, today announced “Works with Kit Check ,” a new program that certifies which hospital solutions are compatible with Kit Check’s pharmacy kit management software. The program is designed … Read More

Bluesight for Controlled Substances screenshot

Kit Check Closes the Diversion Gap with Launch of Bluesight IRIS and Reveals Which Hospital Employees Exhibit Behaviors Consistent with Controlled Substance Theft

Ava MutchlerPress Release

Leading Automated Medication Solutions Provider for Hospital Pharmacies Leverages Machine Learning to Enhance Diversion Identification and Curb Opioid Misuse in Hospitals WASHINGTON (October 1, 2018) – Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of Individual Risk Identification Score (IRIS) to its keystone medication diversion platform. The latest feature of Kit Check’s Bluesight … Read More

Kevin Hutchinson headshot

Kit Check Announces Addition of New Board Member

Jenny HarlettPress Release

WASHINGTON, DC (August 7, 2018) – Kit Check today announced the appointment of Kevin Hutchinson as an independent member to their board of directors. “We are delighted to welcome Kevin to Kit Check’s Board of Directors,” said Kevin MacDonald, co-founder and CEO at Kit Check. “He is both an innovator and a recognized business leader, and he brings a broad … Read More

Kit Check’s Drug Diversion Product Added to Vizient Group Purchasing Contract

Jenny HarlettPress Release

Bluesight for Controlled Substances is the only solution of its kind available to Vizient members WASHINGTON, DC – Kit Check, the leading provider of medication management solutions for hospital pharmacies, announced that its newest product, Bluesight for Controlled Substances (Bluesight CS), has been added to the Vizient group purchasing agreement. Bluesight CS is the only drug auditing solution on the market … Read More

Kit Check Releases New, Smaller ‘Blue Box’ Scanning Station

Jenny HarlettPress Release

Portable low-profile scanning station supports highly accurate medication tracking  from the pharmacy to the OR WASHINGTON, DC – Kit Check has added a new low-profile scanning station to its product line-up. The smaller station incorporates the same features and scanning speed as the larger boxes, but measures 26.99″ wide, 22.95″ deep, and just 9.25″ tall. It is an excellent solution for … Read More